Clinical Trial Update: Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 prospective, randomized, sham-controlled dose-finding trial assessing the safety and efficacy of ZM-02 Injection, a modified optogenetic gene therap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• ZM-02 Injection (Modified Optogenetic Gene Therapy)

Snippet

Sponsor: Zhongmou Therapeutics | Conditions: Retinitis Pigmentosa (RP) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING